Dark Forest Capital Management LP Anavex Life Sciences Corp. Transaction History

Dark Forest Capital Management LP

  • $520 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$6.55 - $9.37 $75,521 - $108,036
11,530 New
11,530 $75,000
Q1 2023

May 12, 2023
BUY
$8.32 - $11.75 $5,000 - $7,061
601 New
601 $5,000
Q1 2022

May 13, 2022
SELL
$9.74 - $17.69 $60,280 - $109,483
-6,189 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$16.88 - $23.31 $104,470 - $144,265
6,189 New
6,189 $107,000

Others Institutions Holding AVXL

# of Institutions
152
Shares Held
26.5M
Call Options Held
674K
Put Options Held
811K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $436M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email